• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols Methoxyphenols

Introduction to 2-(2-hydroxypropyl)-5-methoxyphenol (CAS No. 82700-27-4)

2-(2-hydroxypropyl)-5-methoxyphenol, identified by the Chemical Abstracts Service Number (CAS No.) 82700-27-4, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, featuring a hydroxypropyl side chain attached to a methoxy-substituted phenol core, exhibits a unique structural framework that positions it as a versatile intermediate in the development of various pharmacologically active agents. The presence of both hydroxyl and methoxy functional groups imparts distinct reactivity, making it a valuable candidate for further chemical manipulation and functionalization.

The structural motif of 2-(2-hydroxypropyl)-5-methoxyphenol is characterized by its aromatic ring system, which is a common scaffold in many biologically active compounds. The methoxy group at the 5-position enhances the lipophilicity of the molecule while the hydroxypropyl chain introduces both hydrophilicity and potential for further derivatization. This balance between hydrophobic and hydrophilic regions makes it an attractive candidate for drug design, particularly in formulations requiring solubility and bioavailability optimization.

In recent years, there has been growing interest in phenolic derivatives due to their demonstrated pharmacological properties. Studies have highlighted the potential of compounds containing both hydroxyl and methoxy groups in modulating various biological pathways. For instance, research has indicated that such structures may exhibit antioxidant, anti-inflammatory, and antimicrobial activities. The specific arrangement of these functional groups in 2-(2-hydroxypropyl)-5-methoxyphenol suggests that it could serve as a precursor for developing novel therapeutic agents targeting these mechanisms.

The synthesis of 2-(2-hydroxypropyl)-5-methoxyphenol typically involves multi-step organic transformations, often starting from commercially available aromatic precursors. One common synthetic route includes the methylation of 5-hydroxyphenol derivatives followed by the introduction of the hydroxypropyl group via nucleophilic addition or etherification reactions. Advances in catalytic methods have also enabled more efficient and sustainable synthetic pathways, reducing waste and improving yields. These developments are crucial for scaling up production while adhering to environmental and economic considerations.

From a pharmaceutical perspective, the versatility of 2-(2-hydroxypropyl)-5-methoxyphenol lies in its ability to be further modified to create libraries of analogs with tailored properties. For example, additional functionalization at the aromatic ring or along the hydroxypropyl chain can lead to compounds with enhanced binding affinity or selectivity for specific biological targets. High-throughput screening (HTS) techniques combined with computational modeling have accelerated the process of identifying promising candidates from such chemical libraries.

Recent studies have explored the pharmacokinetic behavior of related phenolic compounds, providing insights into how structural features influence absorption, distribution, metabolism, and excretion (ADME). The presence of both polar (hydroxyl) and non-polar (methyl) groups in 2-(2-hydroxypropyl)-5-methoxyphenol suggests that it may exhibit moderate oral bioavailability and reasonable tissue distribution. However, detailed pharmacokinetic studies are necessary to fully characterize its behavior in vivo.

The potential applications of 2-(2-hydroxypropyl)-5-methoxyphenol extend beyond traditional pharmaceuticals. Its structural features make it suitable for use as an intermediate in fine chemical synthesis, particularly in industries requiring high-purity aromatic compounds. Additionally, its antioxidant properties may find applications in food preservation or cosmetic formulations aimed at protecting against oxidative stress.

In conclusion, 2-(2-hydroxypropyl)-5-methoxyphenol (CAS No. 82700-27-4) represents a promising compound with diverse applications in pharmaceutical research and industrial chemistry. Its unique structural characteristics offer opportunities for developing novel therapeutic agents while serving as a valuable building block in synthetic chemistry. As research continues to uncover new biological activities and synthetic methodologies, the significance of this compound is likely to grow further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)